A Bivalent Omicron-Containing Booster Vaccine against Covid-19Spyros Chalkias, Rituparna Das, Charles Harper et al.|New England Journal of Medicine|2022Cited by 649
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trialSpyros Chalkias, Rituparna Das, Biliana Nestorova et al.|Nature Medicine|2022Cited by 144
Safety and Immunogenicity of XBB.1.5-Containing mRNA VaccinesSpyros Chalkias, Rituparna Das, Nichole McGhee et al.|medRxiv|2023Cited by 79
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim resultsSpyros Chalkias, Rituparna Das, Jordan L. Whatley et al.|Nature Medicine|2023Cited by 77
A Bivalent Omicron-containing Booster Vaccine Against Covid-19Spyros Chalkias, Rituparna Das, Charles Harper et al.|medRxiv|2022Cited by 76